Newcomer Lee Nisley has filed 6 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 112000 shares of Coherus Oncology, Inc. ($CHRS) on June 12, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Coherus Oncology, Inc. | $CHRS | Newcomer Lee Nisley | Not found | A | Stock Option (Right to Buy) | 112000 | $0.00 | 112,000.0000 | 115,857,780 | 9999.99% | 0.10% |
| June 5, 2025 | MYRIAD GENETICS INC | $MYGN | Newcomer Lee Nisley | Director | A | Common Stock | 49796 | $0.00 | 132,141.0000 | 91,309,064 | 60.47% | 0.05% |
| June 6, 2024 | MYRIAD GENETICS INC | $MYGN | Newcomer Lee Nisley | Director | A | Common Stock | 15695 | $0.00 | 82,345.0000 | 0 | 23.55% | 0.00% |
| June 3, 2024 | Coherus Oncology, Inc. | $CHRS | Newcomer Lee Nisley | Not found | A | Stock Option (Right to Buy) | 112000 | $0.00 | 112,000.0000 | 112,749,306 | 9999.99% | 0.10% |
| May 13, 2024 | MYRIAD GENETICS INC | $MYGN | Newcomer Lee Nisley | Director | S | Common Stock | 6200 | $25.30 | 66,650.0000 | 0 | 8.51% | 0.00% |
| June 1, 2023 | MYRIAD GENETICS INC | $MYGN | Newcomer Lee Nisley | Director | A | Common Stock | 15151 | $0.00 | 72,850.0000 | 0 | 26.26% | 0.00% |